|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
53069104
???header.onlineuser??? :
1032
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"behrens f"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
|
Nash, P; Mease, PJ; Fleishaker, D; Wu, J; Coates, LC; Behrens, F; Gladman, DD; Kivitz, AJ; Wei, JC; Shirinsky, I; Menon, S; Romero, AB; Fallon, L; Hsu, MA; Wang, CS; Kanik, KS |
| 中山醫學大學 |
2020 |
TOFACITINIB AS MONOTHERAPY FOLLOWING METHOTREXATE WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH OPEN-LABEL TOFACITINIB plus METHOTREXATE: A RANDOMISED, PLACEBO-CONTROLLED SUBSTUDY OF OPAL BALANCE
|
Nash, P; Coates, LC; Mease, PJ; Kivitz, A; Gladman, DD; Behrens, F; Wei, JCC; Fleishaker, D; Wu, J; Wang, C; Romero, AB; Fallon, L; Hsu, MA; Kanik, K |
| 臺大學術典藏 |
2018 |
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2
|
Genovese M.C.;Combe B.;Kremer J.M.;Tsen-Fang Tsai;Behrens F.;Adams D.H.;Lee C.;Kerr L.;Nash P.; Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. |
| 臺大學術典藏 |
2018 |
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2
|
Genovese M.C.;Combe B.;Kremer J.M.;Tsen-Fang Tsai;Behrens F.;Adams D.H.;Lee C.;Kerr L.;Nash P.; Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. |
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
